MARKET

FPRX

Five Prime
FPRX
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-16.5982
103.12
6.57
1,769,737,102.00
Amgen Lung-Cancer Drug That Targets Mutation Cleared in U.S.
Bloomberg · 05/28 17:04
Amgen Ducks Supreme Court Review of Patents on Enbrel Drug
Bloomberg · 05/17 13:35
Amgen completes $1.9B acquisition of Five Prime Therapeutics
Amgen (AMGN) announces that it has completed its previously announced tender offer to purchase all outstanding shares of Five Prime Therapeutics (FPRX) in a deal valued at ~$1.9B."Five Prime fits
Seekingalpha · 04/16 12:42
8-K: FIVE PRIME THERAPEUTICS, INC.
(EDGAR Online via COMTEX) -- 2021-04-15 false 0001175505 0001175505 2021-04-15 2021-04-15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C....
Edgar Online - (EDK = 8-Ks/S1/S-4) · 04/15 21:33
BRIEF-Five Prime Says U.S. FDA Approved Co's Request For Breakthrough Therapy Designation For Bemarituzumab
reuters.com · 04/15 21:04
Axitinib Market Size, Share, Trend 2021, Industry Overview, Outlook, Trends Evaluation, Geographical Segmentation, Business Challenges and Opportunity Analysis till 2026
Apr 15, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." The “Axitinib Market” Research Report...
The Express Wire · 04/15 07:27
Cancer Angiogenesis Inhibitors Market Research Report by Type, by Product, by Application - Global Forecast to 2027 - Cumulative Impact of COVID-19
Apr 06, 2021 (Market Stats News via COMTEX) -- A new market research report titled "Global Cancer Angiogenesis Inhibitors Market 2021 Analysis and Industry...
Market Stats News · 04/06 21:10
Global Cytotoxic T Lymphocyte Protein 4 Market Trend Survey 2021-2027 with Top Countries Data: Industry Insights by Players, Regional Segmentation, Growth, Applications, Major Drivers, Value and Foreseen | With Covid-19 Analysis
Apr 05, 2021 (The Expresswire) -- Global “Cytotoxic T Lymphocyte Protein 4 Market” research report (2021-2027) covers the market outline and topographical...
The Express Wire · 04/05 05:03
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of FPRX. Analyze the recent business situations of Five Prime through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 8 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average FPRX stock price target is 37.17 with a high estimate of 38.00 and a low estimate of 33.00.
EPS
Institutional Holdings
Institutions: 176
Institutional Holdings: 40.16M
% Owned: 86.24%
Shares Outstanding: 46.57M
TypeInstitutionsShares
Increased
41
7.52M
New
53
16.43M
Decreased
24
9.10M
Sold Out
21
2.04M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
  • All
  • Financials
  • Insiders
More

Webull offers kinds of Five Prime stock information, including NASDAQ:FPRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FPRX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading FPRX stock methods without spending real money on the virtual paper trading platform.